Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 166 Polycystic Ovary Syndrome 23 Neoplasm Metastasis 10 Osteoporosis 7 Neoplasms 6 Infertility 6 Endometrial Neoplasms 5 Carcinoma, Intraductal, Noninfiltrating 5 Ovarian Neoplasms 4 Breast Carcinoma In Situ 4 Arthralgia 4 Recurrence 3 Hereditary Sensory and Autonomic Neuropathies 3 Carcinoma, Ductal, Breast 3 Breast Neoplasms, Male 3 Breast Cancer Metastatic 3 Advanced Breast Cancer 3 Triple Negative Breast Neoplasms 2 Pain 2 Leiomyoma 2 Fallopian Tube Neoplasms 2 Estrogen Receptor-positive Breast Cancer 2 Carcinoma, Lobular 2 Bone Diseases, Metabolic 2 Uterine Neoplasms 1 Patient Acceptance of Health Care 1 Ovarian Cysts 1 Osteitis Deformans 1 Obesity 1 Neoplastic Cells, Circulating 1

Interventions

palbociclib 1 Letrozole 1 Fluorouracil 1 Epirubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neoadjuvant Operable Breast Cancer × Letrozole × Clear all

NCT02400567 2022-03-15

NeoPAL

UNICANCER

Phase 2 Completed

Neoadjuvant Operable Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡